Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001721464 | SCV000535269 | likely benign | not provided | 2021-06-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001721464 | SCV002491901 | benign | not provided | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002319496 | SCV002608677 | likely benign | Cardiovascular phenotype | 2020-11-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004539909 | SCV004763235 | likely benign | ALPK3-related disorder | 2020-09-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |